Bringing the fundamentals into focus…
Back to Sana Biotechnology, Inc.
How Sana Biotechnology, Inc. stacks up
SANA · against 480 other Healthcare companies of similar size
Overall
11/ 100
Near the bottom of its peers.
Ranked #475 of 481 · scores higher than 1% of peers
Bars: peers in each 10-point band of the overall score13 peers with an overall score of 10–19, including SANA · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around SANA| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 2 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 3 | 2.9B HKD (≈$365M) | 84 | 99 | 63 | 86 | 0 / 2 | |
| 4 | 7.5B CNY (≈$1.1B) | 82 | 72 | 64 | 96 | 0 / 2 | |
| 5 | 433M USD | 81 | 96 | 99 | 99 | 2 / 2 | |
| 470 | 1.0B EUR (≈$1.1B) | 16 | 0 | 37 | 17 | 2 / 2 | |
| 472 | 1.3B USD | 15 | 8 | 29 | 9 | 2 / 2 | |
| 473 | 5.1B CNY (≈$709M) | 12 | 0 | 2 | 29 | 2 / 2 | |
| 473 | 522M USD | 12 | 8 | 13 | 19 | 2 / 2 | |
| 475 | 730M USD | 11 | 8 | — | 9 | 2 / 2 | |
| 476 | 5.2B CNY (≈$723M) | 9 | 0 | 5 | 29 | 2 / 2 | |
| 477 | 427M USD | 7 | 8 | — | 1 | 2 / 2 | |
| 478 | 1.2B USD | 6 | 8 | 11 | 0 | 2 / 2 | |
| 478 | 453M USD | 6 | 8 | — | 4 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score